Table 2 Joinpoint analysis of age−adjusted incidence rates per 100 000, AYAs aged 15–39 years in Western Australia, 1982–2007
From: Cancer incidence and mortality trends in Australian adolescents and young adults, 1982–2007
Incidence rates, Males | Incidence rates , Females | |||||||
|---|---|---|---|---|---|---|---|---|
Trend 1 | Trend 2 | Trend 1 | Trend 2 | |||||
Diagnostic Groups | Period | APC 95% CIc | Period | APC 95% CI | Period | APC 95% CI | Period | APC 95% CI |
All Tumours | 82 − 00 | 1.5* ( 0.9; 2.1) | 00 − 07 | −1.4*(-3.4;0.7) | 82 − 07 | −0.1* (-0.2; 0.4) | ||
Leukaemia | 82 − 07 | 0.8 *(-0.7; 2.4) | 82 − 07 | 0.0* (-2.1; 2.1) | ||||
Myeloid | 82 − 07 | −0.3* (-2.1; 1.6) | 82 − 07 | −0.4* (-2.6; 2.0) | ||||
Lymphocytic | 82 − 07 | 3.6* ( 0.1; 7.2) | 82 − 07 | −1.5* (-4.5; 1.6) | ||||
Lymphoma | 82 − 07 | 0.0* (-1.2; 1.3) | 82 − 07 | 1.4* (-0.3; 3.1) | ||||
NHL | 82 − 07 | 0.9* (-0.6; 2.4) | 82 − 07 | 0.5* (-1.5; 2.5) | ||||
HL | 82 − 07 | −1.5* (-3.3; 0.3) | 82 − 07 | 2.6* ( 0.6; 4.7) | ||||
CNS | 82 − 07 | −1.2* (-2.3; 0.1) | 82 − 07 | −1.2* (-3.2; 0.8) | ||||
Bone Tumor | 82 − 07 | −0.1* (-2.0; 1.9) | 82 − 07 | 0.0* (-2.7; 2.8) | ||||
Soft Tissue | 82 − 07 | −1.2* (-2.9; 0.4) | 82 − 07 | 0.8* (-1.1; 2.7) | ||||
Germ Cell | 82 − 07 | 2.6* ( 1.6; 3.6) | 82 − 07 | 0.1* (-2.7; 3.0) | ||||
Gonadal | 82 − 07 | 2.6* ( 1.8; 3.9) | 82 − 07 | −0.1* (-3.6; 3.4) | ||||
Non-gonadal | 82 − 07 | −0.6* (-3.7; 2.5) | 82 − 07 | 0.2* (-3.6; 4.2) | ||||
Melanoma | 82 − 00 | 3.5* ( 2.3; 4.6) | 00 − 07 | −5.3*(-9.1;-1.4) | 82 − 99 | 1.6* ( 0.0; 3.1) | 99 − 07 | −3.8*(-7.7; 0.3) |
Carcinoma | 82 − 07 | 1.0* ( 0.4; 1.5) | 82 − 07 | 0.3* (-0.1; 0.7) | ||||
Breast | na | na | 82 − 07 | 0.5* ( 0.0; 0.9) | ||||
Colon & Rectum | 82 − 07 | −0.4* (-1.7; 1.0) | 82 − 07 | 1.4* ( 0.1; 2.7) | ||||
Ovary | na | na | 82 − 07 | −0.3* (-2.3; 1.9) | ||||
Lung | 82 − 07 | −2.6* (-4.3;-0.9) | 82 − 07 | 0.4* (-1.3; 2.0) | ||||
Cervix Uteri | na | na | 82 − 07 | −2.7* (-3.5;-1.8) | ||||
Thyroid | 82 − 07 | 4.0* ( 2.0; 6.1) | 82 − 00 | 2.1* ( 0.9; 3.2) | 00 − 07 | 13.8*(-0.6;30.3) | ||
Lip & Oral Cavity | 82 − 07 | 0.6* (-0.7; 2.0) | 82 − 07 | 1.1* (-1.1;-3.3) | ||||